News

image
Expanding the Frontiers of Neuroscience: TFS Strengthens Its Gene Therapy Portfolio in Neurodegenerative Diseases

Expanding the Frontiers of Neuroscience: TFS Strengthens Its Gene Therapy Portfolio in Neurodegenerative Diseases

TFS HealthScience, a leading global Contract Research Organization, is expanding its ophthalmology business unit with new leadership talent and enhanced delivery capabilities to meet rising demand for specialized clinical trial…
November 17, 2025
TFS HealthScience achieves SBTi validation for its science-based climate targets, marking a major milestone toward a net-zero future.
TFS HealthScience Secures SBTi Validation, Advancing Its Commitment to a Net-Zero Future

TFS HealthScience Secures SBTi Validation, Advancing Its Commitment to a Net-Zero Future

TFS HealthScience has received validation from the Science Based Targets initiative (SBTi) for its near-term and net-zero greenhouse gas reduction goals, underscoring its commitment to science-based decarbonization and a healthier,…
October 23, 2025
TFS HealthScience Strengthens Global Ophthalmology Unit with Strategic Hires and Integrated Delivery Model
TFS HealthScience Strengthens Global Ophthalmology Unit with Strategic Hires and Integrated Delivery Model

TFS HealthScience Strengthens Global Ophthalmology Unit with Strategic Hires and Integrated Delivery Model

TFS HealthScience, a leading global Contract Research Organization, is expanding its ophthalmology business unit with new leadership talent and enhanced delivery capabilities to meet rising demand for specialized clinical trial…
July 16, 2025
markus granlund named permanent ceo of tfs healthscience
Markus Granlund Permanent CEO of TFS HealthScience

Markus Granlund Permanent CEO of TFS HealthScience

Markus Granlund, who has been serving as Interim CEO of TFS HealthScience since February 2025, has officially been appointed as the company’s Chief Executive Officer, effective immediately.
June 25, 2025
TFS HealthScience 2024 Sustainability Report cover highlighting ESG achievements, commitment to environmental responsibility, and people-centered clinical research
TFS HealthScience Releases 2024 Sustainability Report, Reinforcing Commitment to People, Patients, and the Planet

TFS HealthScience Releases 2024 Sustainability Report, Reinforcing Commitment to People, Patients, and the Planet

TFS shares ESG progress in its 2024 Sustainability Report, highlighting emissions cuts and a global commitment to people and the planet.
May 26, 2025
TFS HealthScience finalist for Fierce Biotech 2025 CRO Award for Excellence in Global Operations
TFS HealthScience Named Finalist for 2025 Fierce Biotech CRO Award for Excellence in Global Operations

TFS HealthScience Named Finalist for 2025 Fierce Biotech CRO Award for Excellence in Global Operations

Recognition highlights the CRO’s global expansion strategy, sponsor-focused execution, and commitment to operational excellence. LUND, S.E., May 14, 2025 – TFS HealthScience (TFS), a leading global Contract Research Organization (CRO),…
May 14, 2025
Oncology Contract Research Organization (CRO)
TFS HealthScience Expands Collaboration with Oncomatryx for Phase Ib Trial of OMTX705 for Pancreatic Cancer

TFS HealthScience Expands Collaboration with Oncomatryx for Phase Ib Trial of OMTX705 for Pancreatic Cancer

LUND, S.E., May 6, 2025 – TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), is deepening its collaboration with Oncomatryx, a biopharmaceutical company developing novel antibody-drug conjugates (ADCs)…
May 6, 2025